Detalles de la búsqueda
1.
SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments.
J Intern Med
; 293(6): 763-781, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37024264
2.
Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study.
Br J Dermatol
; 188(5): 661-669, 2023 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36703193
3.
Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies.
Eur J Haematol
; 111(2): 229-239, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151174
4.
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
J Immunol
; 207(3): 878-887, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301847
5.
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
J Immunol
; 206(1): 109-117, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208457
6.
Humoral response to two doses of BNT162b2 vaccination in people with HIV.
J Intern Med
; 291(4): 513-518, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34841629
7.
The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema.
J Immunol
; 195(8): 3596-604, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26371246
8.
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.
J Intern Med
; 290(6): 1272-1274, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237190
9.
Diverging humoral and cellular immune responses due to Omicron-a national study from the Faroe Islands.
Microbiol Spectr
; 11(6): e0086523, 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37909772
10.
High anti-SARS-CoV-2 seroprevalence among unvaccinated mother-child pairs from a rural setting in north-eastern Tanzania during the second wave of COVID-19.
IJID Reg
; 6: 48-57, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36466214
11.
Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study.
EBioMedicine
; 93: 104661, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331161
12.
Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodies.
Microbiol Spectr
; : e0179623, 2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738355
13.
Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.
Viruses
; 16(1)2023 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38275946
14.
Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination.
Microbiol Spectr
; : e0494722, 2023 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36877077
15.
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk.
Nat Commun
; 14(1): 5624, 2023 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699890
16.
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis.
J Neuroimmunol
; 384: 578215, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797472
17.
Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection.
J Innate Immun
; 14(4): 355-365, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903692
18.
Prediction of Respiratory Failure and Mortality in COVID-19 Patients Using Long Pentraxin PTX3.
J Innate Immun
; 14(5): 493-501, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066500
19.
Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19.
J Innate Immun
; : 1-14, 2022 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35816998
20.
Prevalence and duration of anti-SARS-CoV-2 antibodies in healthcare workers.
Dan Med J
; 69(5)2022 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35485785